SCHEMBL4454002

SCHEMBL4454002

COc1ccc(-c2ccc(CC=O)cc2C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.43
ALDH1A1 P00352 2/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
ALOX12 P18054 1/20 0.42
FFAR4 Q5NUL3 1/20 0.41
MAOB P27338 3/20 0.40
ABL1 P00519 1/20 0.40
ABCB1 P08183 1/20 0.40
BCR P11274 1/20 0.40
BACE1 P56817 1/20 0.40
MAOA P21397 1/20 0.39
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4455043 0.91 KDM4E (0.45) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL4557297 0.83 KDM4E (0.44) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL4457614 0.81 HSD17B1 (0.49) IDH1
SCHEMBL19287149 0.79 ALDH1A1 (0.59) SMN1; SMN2ALDH1A1TP53CYP3A4ALOX15
SCHEMBL679848 0.77 SMN1; SMN2 (0.55) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL190915 0.77 ALDH1A1 (0.65) SMN1; SMN2ALDH1A1TP53CYP3A4ALOX15
SCHEMBL19722100 0.76 CASP3 (0.55) ALOX15MAOBRAB9AMAPT
SCHEMBL22073083 0.76 DYRK1A (0.52) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL23512347 0.76 KDM4E (0.45) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL30830335 0.76 CYP11B1 (0.47) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013176-A2 DIARYL COMPOUNDS AS NON-STEROIDAL INHIBITORS OF 17-BETA HYDROXYSTEROID DEHYDROGENASE AND/OR STEROID SULPHATASE FOR THE TREATMENT OF OESTROGEN-RELATED DISEASES SUCH AS HORMONE DEPENDENT BREAST CANCER Sterix Limited (GB) 2009-01-14 EP disclosed
WO-2007096647-A2 DIARYL COMPOUNDS AS NON-STEROIDAL INHIBITORS OF 17-BETA HYDROXYSTEROID DEHYDROGENASE AND/OR STEROID SULPHATASE FOR THE TREATMENT OF OESTROGEN-RELATED DISEASES SUCH AS HORMONE DEPENDENT BREAST CANCER STERIX LIMITED (GB) 2007-08-30 WO disclosed